Viewing StudyNCT00464893



Ignite Creation Date: 2024-05-05 @ 5:28 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00464893
Status: COMPLETED
Last Update Posted: 2013-12-04
First Post: 2007-04-23

Brief Title: Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
Sponsor: Neovii Biotech
Organization: Neovii Biotech

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-04
Start Date Type: None
Primary Completion Date: 2009-04
Primary Completion Date Type: ACTUAL
Completion Date: 2013-04
Completion Date Type: ACTUAL
First Submit Date: 2007-04-23
First Submit QC Date: April 23 2007
Study First Post Date: 2007-04-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-12-03
Last Update Post Date: 2013-12-04
Last Update Post Date Type: ESTIMATED